These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2886557)

  • 1. Glutamatergic denervation in Alzheimer's disease--a cautionary note.
    Procter AW; Palmer AM; Bowen DM; Murphy E; Neary D
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):825. PubMed ID: 2886557
    [No Abstract]   [Full Text] [Related]  

  • 2. Region-specific loss of glutamate innervation in Alzheimer's disease.
    Hardy J; Cowburn R; Barton A; Reynolds G; Lofdahl E; O'Carroll AM; Wester P; Winblad B
    Neurosci Lett; 1987 Jan; 73(1):77-80. PubMed ID: 2882446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamate deficits in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):356-8. PubMed ID: 2881984
    [No Abstract]   [Full Text] [Related]  

  • 4. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease.
    Lowe SL; Bowen DM; Francis PT; Neary D
    Neuroscience; 1990; 38(3):571-7. PubMed ID: 1980143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Neurosci Lett; 1988 Mar; 86(1):109-13. PubMed ID: 2896322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamic acid concentration in brains of patients with Alzheimer's disease.
    Lowe SL; Bowen DM
    Biochem Soc Trans; 1990 Jun; 18(3):443-4. PubMed ID: 1973666
    [No Abstract]   [Full Text] [Related]  

  • 7. Glutamate/aspartate-releasing neurons in Alzheimer's disease.
    Procter AW; Palmer AM; Stratmann GC; Bowen DM
    N Engl J Med; 1986 Jun; 314(26):1711-2. PubMed ID: 3713780
    [No Abstract]   [Full Text] [Related]  

  • 8. A postmortem study of amino acid neurotransmitters in Alzheimer's disease.
    Ellison DW; Beal MF; Mazurek MF; Bird ED; Martin JB
    Ann Neurol; 1986 Nov; 20(5):616-21. PubMed ID: 2878639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type.
    Sasaki H; Muramoto O; Kanazawa I; Arai H; Kosaka K; Iizuka R
    Ann Neurol; 1986 Mar; 19(3):263-9. PubMed ID: 2870679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Working hypothesis for the pharmacologic research in the glutamatergic approach to Alzheimer's disease].
    Vamvakides A
    Ann Pharm Fr; 1989; 47(6):329-36. PubMed ID: 2577340
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia.
    Harris K; Lin A; Bhattacharya P; Tran T; Wong W; Ross B
    Adv Exp Med Biol; 2006; 576():263-73; discussion 361-3. PubMed ID: 16802718
    [No Abstract]   [Full Text] [Related]  

  • 12. Hippocampal free amino acids in Alzheimer's disease.
    Tarbit I; Perry EK; Perry RH; Blessed G; Tomlinson BE
    J Neurochem; 1980 Nov; 35(5):1246-9. PubMed ID: 7452316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of excitotoxic mechanisms in Alzheimer's disease.
    May PC
    Neurobiol Aging; 1989; 10(5):606-8; discussion 618-20. PubMed ID: 2572984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamic acid and Alzheimer's disease.
    Arias C; Becerra-García F; Tapia R
    Neurobiology (Bp); 1998; 6(1):33-43. PubMed ID: 9713830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine in relation to amino acid transmitters in Alzheimer's disease.
    Bowen DM; Steele JE; Lowe SL; Palmer AM
    Adv Neurol; 1990; 51():91-6. PubMed ID: 1967197
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper.
    Harrison PJ
    J R Soc Med; 1986 Jun; 79(6):347-52. PubMed ID: 2873250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Brain concentration of glutamic, aspartic, N-acetylaspartic and N-acetylaspartyl-glutamic acids in rats chronically treated with aspartic and N-acetylaspartic acids].
    Curatolo A; D'Arcangelo P; Lino A; Brancati A
    Boll Soc Ital Biol Sper; 1965 Jun; 41(11):588-90. PubMed ID: 5875909
    [No Abstract]   [Full Text] [Related]  

  • 18. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.
    Hyman BT; Van Hoesen GW; Damasio AR
    Ann Neurol; 1987 Jul; 22(1):37-40. PubMed ID: 2443073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl aspartic, aspartic and glutamic acid brain levels in aggressive mice.
    Marcucci F; Giacalone E
    Biochem Pharmacol; 1969 Mar; 18(3):691-2. PubMed ID: 5814485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Concentrations of glutamic acid and aspartic acid in the brain and spinal cord of growing rats].
    Curatolo A; Brancati A; D'Arcangelo P; Lino A
    Arch Fisiol; 1970 Jul; 67(4):273-80. PubMed ID: 5522622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.